Last reviewed · How we verify
RECONVAL CREAM
RECONVAL CREAM is a Small molecule drug developed by Hadassah Medical Organization. It is currently in Phase 2 development.
RECONVAL CREAM is a type of cream used in clinical trials for conditions such as metastatic colorectal cancer and rash due to epidermal growth factor receptor inhibitors. The exact mechanism of RECONVAL CREAM is unknown, as its modality is listed as "Unknown" in ChEMBL.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | RECONVAL CREAM |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI (PHASE2)
- Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RECONVAL CREAM CI brief — competitive landscape report
- RECONVAL CREAM updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI
Frequently asked questions about RECONVAL CREAM
What is RECONVAL CREAM?
Who makes RECONVAL CREAM?
What development phase is RECONVAL CREAM in?
Related
- Manufacturer: Hadassah Medical Organization — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing